ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of and Immune Response to a DNA Vaccine and a Recombinant HIV-1-MVA Vaccine, Separately and in Combination, in Healthy Adults

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00428337
Recruitment Status : Completed
First Posted : January 30, 2007
Last Update Posted : March 4, 2015
Sponsor:
Collaborators:
HIV Vaccine Trials Network
Pharmexa-Epimmune
Bavarian Nordic
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)